Superstring Capital Management LP Novo Cure LTD Transaction History
Superstring Capital Management LP
- $79.3 Billion
- Q2 2024
A detailed history of Superstring Capital Management LP transactions in Novo Cure LTD stock. As of the latest transaction made, Superstring Capital Management LP holds 66,892 shares of NVCR stock, worth $1.02 Million. This represents 1.44% of its overall portfolio holdings.
Number of Shares
66,892Holding current value
$1.02 Million% of portfolio
1.44%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
265Shares Held
77.1MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$184 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$178 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$169 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$45.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$36.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.59B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...